Position in TRVI
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$187,488
+$63,238 QoQ
Shares Held
10,053
-3.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#167
of 218 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vontobel Holding Ltd. holds $98,796,822 across 44 Biotechnology names. TRVI ranks #31 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
81,525 | $40,495,910 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
33,169 | $20,682,197 | |
| 3 | MRNA |
Moderna, Inc.
|
87,541 | $6,130,496 | |
| 4 | BNTX |
BioNTech SE
|
61,238 | $5,698,195 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
153,242 | $4,018,005 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
35,363 | $2,633,836 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
|
40,000 | $2,517,600 | |
| 8 | SLS |
SELLAS Life Sciences Group, Inc.
|
146,762 | $2,166,207 |
All Filings in TRVI
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $187,488 | 10,053 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $124,250 | 10,415 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $134,765 | 10,764 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $200,009 | 21,859 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $136,203 | 24,900 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $197,248 | 31,359 | Shares | Defined | 2025-04-28 | |
| No filing history on record for this holder in this stock. | ||||||